Xcout Intel
AFFINITY BIOSENSORS LLC
Affinity Biosensors manufactures the LifeScale system, a medical technology product that provides rapid antimicrobial susceptibility testing (AST) results for gram-negative bacteria from positive blood cultures. The system uses population-profiling technology to deliver laboratory test results in approximately four hours to assist medical and laboratory professionals.
Subscribe to see AFFINITY BIOSENSORS LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
AFFINITY BIOSENSORS LLC at a glance
AFFINITY BIOSENSORS LLC is a medical diagnostics company headquartered in United States. It has raised at least $62.6M across the 12 funding rounds on record. Its most recent funding round raised $4M in March 2026. Xcout tracks 6 named people at AFFINITY BIOSENSORS LLC, including Kenneth Babcock (CEO).
AFFINITY BIOSENSORS LLC leadership
- Kenneth BabcockCEO
- Michael PfauExecutive Officer
- Charles MamrakDirector
- James IulianoDirector
- Jeffrey HawkinsDirector
- Robert L. JohnsonDirector
AFFINITY BIOSENSORS LLC funding rounds
At least $62.6M raised across the 12 rounds on record. The 3 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $4M | — | |
| SEC Form D filing | $14.4M | — | |
| SEC Form D filing | $3.7M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent AFFINITY BIOSENSORS LLC news
- FundingPrivate placement (Form D)
- FundingPrivate placement (Form D)
AFFINITY BIOSENSORS LLC competitors
A few of AFFINITY BIOSENSORS LLC's closest competitors — see the full list of competitors and alternatives →
Sysmex Astrego is a medical technology company specializing in automated antibiotic susceptibility testing to combat antimicrobial resistance.
Headquartered in Muttenz, Switzerland, Resistell AG is a biotechnology company incorporated in 2018 that develops rapid antibiotic susceptibility testing devices as an innovative alternative to traditional culture-based antibiograms.
Humedics GmbH is a medical technology company based in Berlin, Germany, that specializes in rapid and accurate liver function measurement using the innovative LiMAx test.
Royal Biotech Inc. develops, manufactures, and markets portable diagnostic analysis products, handheld systems, and test kits for clinical, veterinary, food safety, and environmental applications. The company serves public security and health sectors by providing molecular and microfluidic diagnostic devices designed for on-site use.
Magnolia Medical Technologies, Inc. is a medical device company headquartered in Seattle and Bellevue, Washington. The company develops diagnostic and blood collection technologies designed to reduce in-vitro diagnostic errors and improve blood culture accuracy.
QLife Holding develops medical technology products, specifically featuring the Egoo platform for decentralized biomarker and blood testing. The company provides accessible diagnostic equipment designed for patients to use at home.
Get AFFINITY BIOSENSORS LLC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on AFFINITY BIOSENSORS LLC in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 12 funding rounds with the investors in each, and who they co-invest with
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access